搜索页_ Lawrence F. Eichenfield MD¶

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Opening Hours
Collections
Help Via Email

Electronic Information Resources

常用资源

内部出版物

CNKI学位论文(2)

知网期刊论文(1)

在“Elsevier电子期刊”中，命中：2条，耗时：0.0699664 秒

在所有数据库中总计命中：3条

1.OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study

作者：Jon M. Hanifin ; MD^a ; Charles N. Ellis ; MD^b ; Ilona J. Frieden ; MD^c ; Regina Fö ; lster-Holst ; MD^d ; Linda F. Stein Gold ; MD^e ; Angelo Secci ; MD^f ; Angela J. Smith ; PA^f ; Cathy Zhao ; PhD^f ; Elena Kornyeyeva ; MD ; PhD^f ; ^{elena.kornyeyeva@otsuka-us.com" class="auth_mail" title="E-mail the corresponding author} ; Lawrence F. Eichenfield ; MD^g

关键词：atopic dermatitis ; atopic eczema ; OPA-15406 ; phosphodiesterase type 4 inhibitor ; topical agents ; topical calcineurin inhibitor

刊名：Journal of the American Academy of Dermatology

出版年：2016

2.Ustekinumab in adolescent patients age 12 to 17聽years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study

作者：Ian Landells ; MD ; FRCPC^a ; ^{landells@nexusresearch.com" class="auth_mail" title="E-mail the corresponding author} ; Colleen Marano ; PhD^b ; Ming-Chun Hsu ; PhD^b ; Shu Li ; PhD^b ; Yaowei Zhu ; PhD^b ; Lawrence F. Eichenfield ; MD^c ; Peter H. Hoeger ; MD^d ; Alan Menter ; MD^e ; Amy S. Paller ; MS ; MD^f ; Alain Taieb ; MD^g ; Sandra Philipp ; MD^h ; Philippe Szapary ; MD ; MSCE^b ; Bruce Randazzo ; MD ; PhD^b ; ⁱ

关键词：adolescent ; biologic ; children ; pediatric ; psoriasis ; systemic therapy ; ustekinumab

刊名：Journal of the American Academy of Dermatology

出版年：2015

1

按出版年细分(2)

2016年(1)

2015年(1)

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.